Molecular biology of the Rh system: clinical considerations for transfusion in sickle cell disease
Authors:
- Connie M. WesthoffCWConnie M. Westhoff
Open Access
- 1 January 2009
- journal article
- review article
- Published by American Society of Hematology in Hematology-American Society Hematology Education Program
- Vol. 2009 (1) , 178-184
Abstract
The last decade has witnessed an abundance of information detailing the genetic diversity of the RH locus which has exceeded all estimates predicted by serology. Well over 120 RHD and over 60 different RHCE alleles have been documented, and new alleles are still being discovered. For clinical transfusion medicine, RH genetic testing can now be used to determine RHD zygosity, resolve D antigen status, and detect altered RHD and RHCE genes in individuals at risk for producing antibodies to high-incidence Rh antigens, particularly patients with sickle cell disease (SCD).Keywords
This publication has 37 references indexed in Scilit:
- The JAL antigen (RH48) is the result of a change inRHCEthat encodes Arg114TrpTransfusion, 2009
- The Structure and Function of the Rh Antigen ComplexSeminars in Hematology, 2007
- Discontinuing Prophylactic Transfusions Used to Prevent Stroke in Sickle Cell DiseaseNew England Journal of Medicine, 2005
- A flexible array format for large‐scale, rapid blood group DNA typingTransfusion, 2005
- Allelic genes of blood group antigens: A source of human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation DatabaseHuman Mutation, 2003
- Delayed Hemolytic Transfusion Reaction/Hyperhemolysis Syndrome in Children With Sickle Cell DiseasePediatrics, 2003
- Antigen‐matched donor blood in the transfusion management of patients with sickle cell diseaseTransfusion, 1994
- To match or not to match: the question for chronically transfused patients with sickle cell anemiaTransfusion, 1994
- Alloimmunization in Sickle Cell Anemia and Transfusion of Racially Unmatched BloodNew England Journal of Medicine, 1990
- Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapyTransfusion, 1987